No black box warning on record for Venclexta

As of the latest FDA labeling reviewed, Venclexta (VENETOCLAX) does not carry a black box warning. Standard warnings and precautions still apply — see the full Venclexta medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Tumor Lysis Syndrome (TLS): Anticipate TLS; assess risk in all patients. Premedicate with anti-hyperuricemics and ensure adequate hydration. Employ more intensive measures (intravenous hydration, frequent monitoring, hospitalization) as overall risk increases. ( 2.4 , 5.1 ) Neutropenia: Monitor blood counts. Interrupt dosing and resume at same or reduced dose. Consider s

No black box warning on record for Venclexta

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Tumor Lysis Syndrome (TLS): Anticipate TLS; assess risk in all patients. Premedicate with anti-hyperuricemics and ensure adequate hydration. Employ more intensive measures (intravenous hydration, frequent monitoring, hospitalization) as overall risk increases. ( 2.4 , 5.1 ) Neutropenia: Monitor blood counts. Interrupt dosing and resume at same or reduced dose. Consider s

Venclexta Black Box Warning

No black box warning on record for Venclexta

Other warnings & precautions

Venclexta Black Box Warning

No black box warning on record for Venclexta

Other warnings & precautions